To evaluate the long-term efficacy of verteporfin photodynamic therapy (PDT) as the primary treatment for symptomatic circumscribed choroidal hemangioma (CCH).
Blasi, M. A., Tiberti, A. C., Scupola, A., Balestrazzi, A., Colangelo, E., Valente, P., Balestrazzi, E., Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes, <<OPHTHALMOLOGY>>, 2010; 117 (8): 1630-1637. [doi:10.1016/j.ophtha.2009.12.033] [http://hdl.handle.net/10807/43474]
Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes
Blasi;Maria Antonietta; Tiberti;Alessandra Cristiana; Scupola;E; Valente;Paola; Balestrazzi
2010
Abstract
To evaluate the long-term efficacy of verteporfin photodynamic therapy (PDT) as the primary treatment for symptomatic circumscribed choroidal hemangioma (CCH).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
